Table 1 Baseline characteristics of the participants (n = 2171)
From: Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study
Characteristics | Sample (n = 2171) | Benign prostatic hyperplasia | P | |
|---|---|---|---|---|
Yes (n = 516) | No (n = 1655) | |||
Age (year, mean ± SD) | 51.09 ± 15.25 | 67.02 ± 12.83 | 46.13 ± 12.25 | 0.00 |
BMI (kg/m2, mean ± SD) | 25.09 ± 3.03 | 24.73 ± 3.08 | 25.20 ± 3.00 | 0.00 |
Blood pressure [n(%)] | Â | Â | Â | 0.00 |
 Hypertension | 794 (37.4) | 249 (49.3) | 545 (33.7) |  |
 Normotension | 1327 (62.6) | 256 (50.7) | 1071 (66.3) |  |
Periodontal disease [n(%)] | Â | Â | Â | 0.40 |
 No | 1405 (64.7) | 342 (66.3) | 1063 (64.2) |  |
 Yes | 766 (35.3) | 174 (33.7) | 592 (35.8) |  |
FBG (ng/ml, mean ± SD) | 5.64 ± 1.45 | 5.96 ± 1.62 | 5.54 ± 1.37 | 0.00 |
LDL-C (mmol/L, mean ± SD) | 2.77 ± 0.70 | 2.75 ± 0.72 | 2.78 ± 0.69 | 0.43 |
Triglycerides (mmol/L, mean ± SD) | 1.55 ± 1.01 | 1.39 ± 0.92 | 1.61 ± 1.04 | 0.00 |
HDL-C (mmol/L, mean ± SD) | 1.23 ± 0.25 | 1.23 ± 0.25 | 1.23 ± 0.26 | 0.86 |
TC (mmol/L, mean ± SD) | 4.63 ± 0.86 | 4.63 ± 0.91 | 4.63 ± 0.85 | 0.89 |
ESR (mm/h, mean ± SD) | 5.51 ± 6.01 | 8.24 ± 8.36 | 4.66 ± 4.74 | 0.00 |
Uric acid (μmol/L, mean ± SD) | 320.44 ± 72.01 | 314.48 ± 71.63 | 322.31 ± 72.06 | 0.03 |
Creatinine (μmol/L, mean ± SD) | 81.25 ± 13.04 | 80.03 ± 14.13 | 81.64 ± 12.65 | 0.02 |
Urea nitrogen (mmol/L, mean ± SD) | 5.13 ± 1.21 | 5.20 ± 1.39 | 5.10 ± 1.14 | 0.13 |
Prostate volume (g, mean ± SD) |  | 41.03 ± 18.11 | NR | NA |
 ≤ 60 g (n = 444) |  | 35.93 ± 9.24 | NR |  |
 > 60 g (n = 62) |  | 77.92 ± 22.79 | NR |  |